Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of ZuraPrep and ZuraPrep Without IPA in Healthy Volunteers
NCT02160587Phase 1Completed
- Sponsor
- Zurex Pharma
- Start
- Jul 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, double-blind, single-arm trial of ChloraPrep in surgical site infection (SSI), sponsored by Zurex Pharma. Primary endpoint: Skin sites evaluated and graded for irritancy or sensitization. Started Jul 2014; status: completed.
02
Drugs
ChloraPrep
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02160587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160587.